Arrowstreet Capital, Limited Partnership Gilead Sciences, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

$108 Billion
Q1 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 5,046,433 shares of GILD stock, worth $346 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

5,046,433

Previous 8,378,374 39.77%

Holding current value

$346 Million

Previous $679 Million 45.54%

% of portfolio

0.34%

Previous 0.71%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $239 Million - $291 Million	-3,331,941 Reduced 39.77%	5,046,433 $370 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $135 Million - $153 Million	-1,839,296 Reduced 18.0%	8,378,374 $679 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $98.4 Million - $107 Million	1,330,560 Added 14.97%	10,217,670 $766 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $52.9 Million - $60.3 Million	695,909 Added 8.5%	8,887,110 $685 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $1.92 Million - $2.19 Million	-24,833 Reduced 0.3%	8,191,201 $680 Million

Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $238 Million - $342 Million	-3,820,541 Reduced 31.74%	8,216,034 $705 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $216 Million - $247 Million	-3,631,610 Reduced 23.18%	12,036,575 $743 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $135 Million - $152 Million	-2,334,029 Reduced 12.97%	15,668,185 $968 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $797 Million - $999 Million	13,764,169 Added 324.78%	18,002,214 $1.07 Billion
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $273 Million - $309 Million	4,201,326 Added 11441.83%	4,238,045 $308 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $39.3 Million - $42.4 Million	-580,425 Reduced 94.05%	36,719 $2.57 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $39.2 Million - $42.8 Million	617,144 New	617,144 $42.5 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $185 Million - $211 Million	-3,082,197 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $53.8 Million - $61.3 Million	949,275 Added 44.51%	3,082,197 $180 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $9.47 Million - $11.9 Million	152,480 Added 7.7%	2,132,922 $135 Million
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $63.7 Million - $74 Million	881,065 Added 80.14%	1,980,442 $152 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $43.3 Million - $55.4 Million	-690,815 Reduced 38.59%	1,099,377 $82.2 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $868,102 - $954,884	14,088 Added 0.79%	1,790,192 $116 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $114 Million - $125 Million	-1,818,029 Reduced 50.58%	1,776,104 $113 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $21.1 Million - $23.7 Million	341,000 Added 10.48%	3,594,133 $243 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $130 Million - $145 Million	2,073,539 Added 175.78%	3,253,133 $211 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $9.27 Million - $12.1 Million	-153,107 Reduced 11.49%	1,179,594 $73.8 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $83.7 Million - $92.7 Million	-1,174,582 Reduced 46.85%	1,332,701 $103 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $43.4 Million - $50.6 Million	-668,464 Reduced 21.05%	2,507,283 $178 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $7.68 Million - $9.36 Million	105,420 Added 3.43%	3,175,747 $239 Million
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $217 Million - $254 Million	3,046,047 Added 12545.5%	3,070,327 $220 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.75 Million - $2.08 Million	24,280	24,280 $1.97 Million

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Gilead Sciences, Inc. Transaction History